Tokuda et al. [10]

Karakiewicz et al. [9]

Wright et al. [11]

Publishing year

Patients source

Period of data extraction

Number of patients

Median follow-up time, months (range)

Incidence (%)

CSS rate at 1 year, %

CSS rate at 3 years, %

Median age, years (range)

Male gender, n (%)

Symptomatic at presentation, n (%)

Median tumor size, cm (range)

Advance T stage (T3 - 4), n (%):

Regional nodal involvement (N1-2), n (%):

Distance Metastasis (M1), n. (%):

High grade, n. (%):

Fuhrmann G3 - 4

Poorly/undifferentiated

Surgery for primary tumor, n. (%):

Chemotherapy, n. (%)

Immunotherapy, n (%)

2006

Japan

2001-2003

81

15.0 (0.5 - 157.0)

-

69.0%

45.3%

58.2 (26 - 79)

58 (71.6%)

53 (65.4%)

6 (1 - 15)

46 (57.0%)

27 (33.3%)

26 (32.1%)

80 (98.8%)

-

80 (98.8%)

17 (21.0%)

34 (42.0%)

2007

European

1984-2001

41

2.9 (0.1 - 19.7)

0.6%

86.1%

^†68.0%

64.0 (40 - 90)

31 (75.6%)

59 (72.8%)

6.1 (2.0 - 18.0)

33 (80.5%)

20 (48.8%)

8 (19.5%)

32 (78.0%)

-

41 (100.0%)

-

-

2009

USA

2001-2005

160

19.0

1.2% in Blacks

0.4% in Whites

70.0%

58.0%

62.0 (-)

112 (70%)

-

^‡5.9 (-)

53 (33.1%)

24 (15.0%)

44 (27.5%)

§70.0%

135.(84.4%)

-

-